Cellular localization of tumor necrosis factor-alpha following acute spinal cord injury in adult rats
- PMID: 11393259
- DOI: 10.1089/089771501300227369
Cellular localization of tumor necrosis factor-alpha following acute spinal cord injury in adult rats
Abstract
Posttraumatic inflammatory reaction may contribute to secondary injury after traumatic spinal cord injury (SCI). Expression of tumor necrosis factor-alpha (TNF-alpha), a key inflammatory mediator, has been demonstrated in the injured cord. However, the specific cell types that are responsible for TNF-alpha expression after SCI remain to be identified. In the present study, cellular sources of TNF-alpha were examined in rats that received a spinal cord impact injury at the 9th thoracic (T9) level. Here we demonstrate that, within hours after SCI, increased TNF-alpha immunoreactivity was localized in neurons, glial cells (including astrocytes, oligodendrocytes, and microglia), and endothelial cells in areas of the spinal cord adjacent to the lesion site. Myelin breakdown was noted in oligodendrocytes that are immunopositive for TNF-alpha. In sham-operated controls, a low level of TNF-alpha immunoreactivity was detected. In antigen-absorption experiments, no TNF-alpha immunoreactivity was detected, indicating the specificity of TNF-alpha immunocytochemistry in the present study. Results suggest that various cell types, including neurons, glial cells, and vascular endothelial cells, contribute to TNF-alpha production in the injured cord.
Similar articles
-
Role of tumor necrosis factor-alpha in neuronal and glial apoptosis after spinal cord injury.Exp Neurol. 2000 Nov;166(1):190-5. doi: 10.1006/exnr.2000.7494. Exp Neurol. 2000. PMID: 11031095
-
Methylprednisolone reduces spinal cord injury in rats without affecting tumor necrosis factor-alpha production.J Neurotrauma. 2001 May;18(5):533-43. doi: 10.1089/089771501300227332. J Neurotrauma. 2001. PMID: 11393256
-
High mobility group box 1 is upregulated after spinal cord injury and is associated with neuronal cell apoptosis.Spine (Phila Pa 1976). 2010 May 15;35(11):1109-15. doi: 10.1097/BRS.0b013e3181bd14b6. Spine (Phila Pa 1976). 2010. PMID: 20195207
-
Anti-TNF therapy in the injured spinal cord.Trends Pharmacol Sci. 2011 Feb;32(2):107-15. doi: 10.1016/j.tips.2010.11.009. Epub 2010 Dec 23. Trends Pharmacol Sci. 2011. PMID: 21185611 Review.
-
Cell death in models of spinal cord injury.Prog Brain Res. 2002;137:37-47. doi: 10.1016/s0079-6123(02)37006-7. Prog Brain Res. 2002. PMID: 12440358 Review.
Cited by
-
Plasma Cytokines Level and Spinal Cord MRI Predict Clinical Outcome in a Rat Glial Scar Cryoinjury Model.Biomedicines. 2022 Sep 21;10(10):2345. doi: 10.3390/biomedicines10102345. Biomedicines. 2022. PMID: 36289607 Free PMC article.
-
Low-Level Laser Irradiation Improves Motor Recovery After Contusive Spinal Cord Injury in Rats.Tissue Eng Regen Med. 2017 Jan 17;14(1):57-64. doi: 10.1007/s13770-016-0003-4. eCollection 2017 Feb. Tissue Eng Regen Med. 2017. PMID: 30603462 Free PMC article.
-
Effects of Dietary Vitamin E Supplementation in Bladder Function and Spasticity during Spinal Cord Injury.Brain Sci. 2018 Feb 26;8(3):38. doi: 10.3390/brainsci8030038. Brain Sci. 2018. PMID: 29495419 Free PMC article.
-
Neuroprotection and its molecular mechanism following spinal cord injury.Neural Regen Res. 2012 Sep 15;7(26):2051-62. doi: 10.3969/j.issn.1673-5374.2012.26.007. Neural Regen Res. 2012. PMID: 25624837 Free PMC article. Review.
-
Effects of zileuton and montelukast in mouse experimental spinal cord injury.Br J Pharmacol. 2008 Feb;153(3):568-82. doi: 10.1038/sj.bjp.0707577. Epub 2007 Dec 3. Br J Pharmacol. 2008. PMID: 18059327 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical